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ABSTRACT
Recently, it was found that bacterial and eukaryotic transcripts are capped with cellular cofactors
installed by their respective RNA polymerases (RNAPs) during transcription initiation. We now show
that mitochondrial RNAP efficiently caps transcripts with ADP – containing cofactors. However, a
functional role of universal RNAP – catalysed capping is not yet clear. KEYWORDS
transcription; RNA
polymerase; RNA capping;
non-canonical capping;
NAD+; FAD; dephospho
coenzymeA; UDP-GlcNAc;
mitochondrial RNA
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The discovery of non-canonical transcript
capping
Capping of RNA is no longer seen as an exclusive fea-
ture of eukaryotes, thanks to the recent discovery of
bacterial transcripts capped by NAD+ and 3 0-dephos-
phocoenzyme A (DP-CoA) [1,2]. NAD+ is the only
cap investigated in vivo in E. coli, and is found on a
number of small RNAs (sRNAs) and messenger RNAs
(mRNAs). In addition, a number of currently unchar-
acterised moieties were found attached to E.coli cellu-
lar RNA which could potentially also serve as 5’ RNA
caps [3]. The extent of NAD+ modification (NADyla-
tion) in the cell varies greatly for different RNA spe-
cies. The RNA species that are most heavily
NADylated in vivo [1] are listed on Figure 1A. Even
for these species, only a relatively small proportion of
the transcripts are capped with NAD+ (13% in the
case of most heavily NADylated species, namely
RNAI – the antisense RNA involved in the regulation
of pUC19 plasmid replication [1]). More recently
NAD+ capping was shown not to be unique for bacte-
ria, as NADylated RNAs were found in vivo in Saccha-
romyces cerevisiae and human cells [4,5].
The search for an enzyme that can potentially
NADylate RNA transcripts was relatively straightfor-
ward, as bacterial RNA polymerase (RNAP) was shown
previously to use NAD+ as an initiating nucleotide
(given its ADP moiety and free 3’ hydroxyl group) [6].
Studies by Bird et al., and Julius and Yuzenkova, using
promoter-specific assays, demonstrated that capping
can be performed by RNAP on promoters where tran-
scription starts with A [7,8]. These studies showed that
the Km for NAD
+ in transcription initiation was much
lower than the in vivo concentration of NAD+
(Figure 1B). Furthermore, Bird et al. observed a strong
correlation between the extent of NADylation of a cho-
sen transcript in vivo and the efficiency of NADylation
by RNAP in vitro [7]. Eukaryotic RNApol II was also
shown to be able to incorporate NAD+, suggesting that
the NADylated transcripts observed in vivo are also
capped by RNAP [7].
Other ADP-containing cofactors were shown to be
efficiently incorporated at the 5’ end of RNA by
RNAP, such as FAD and 3 0-dephosphocoenzyme A
(but not NADP and NADPH) [7,8]. The efficiency of
incorporation for these compounds and their concen-
tration in the cell are lower than those for NAD+, sug-
gesting that the possible abundance of these caps is
also lower [9].
Cell wall precursors are potentially another class
of prokaryotic capping molecules
Dinucleotides UDP-Glucose and UDP-GlcNAc, the
precursors of bacterial cell wall synthesis, are even more
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abundant than NAD+ in E. coli cells grown on rich
media (Figure 1B). We recently found that for pro-
moters coding for U at position +1, their RNA tran-
scripts can be efficiently capped in vitro by E. coli RNA
polymerase with UDP-GlcNAc and UDP-Glucose [8].
The relatively low Km for the incorporation of these sub-
strate at the 5’ end of the RNA transcripts by RNAP,
favours the probability of in vivo capping by UDP-
GlcNAc and UDP-Glucose, by analogy with NAD+
(Figure 1B). Although less than 10% of E. coli promoters
code for U at position +1, a link between gene expres-
sion and cell wall synthesis could be of potential signifi-
cance for coordinating biomass and cell wall synthesis.
The ability of RNAP to incorporate variety of known
nucleotide-containing molecules at the 5’ position of
transcript, as well as a number of identified but unchar-
acterised RNA modifying moieties [3], suggests the
existence of a wide repertoire of RNA caps in the cell.
At least two domains of bacterial RNAP
determine efficiency of NAD+ capping
We showed that initiation with NAD+ stabilises short
transcripts and favours promoter escape by E. coli
RNAP in vitro [8]. Whether this stabilisation comes
via additional base pairing of cap with the -1 position
of the promoter (since NAD+ has a nicotine mononu-
cleotide moiety, which may potentially interact with
DNA template at -1 position) remains somewhat con-
troversial. Bird et al. showed that the identity of the
base at position -1 (-1A vs -1C) affects the efficiency
of capping [7]. However, our data suggests that the
base at -1 affects initiation in general, without chang-
ing the preference for NAD+ [8]. Indeed, in the crystal
structure of the RNAP initiation complex with a short
NADylated transcript, the NMN moiety does not
make contacts with DNA but rather faces the protein
[7] (Figure 1C). Also, in agreement with the crystal
structure, we showed that amino acid changes in the
rifampicin-binding pocket of RNAP strongly affected
the efficiency of NAD+ incorporation, suggesting that
observed stabilisation of short capped RNAs is due to
interactions between the NAD+ cap and the RNAP
rifampicin-binding pocket [8] (Figure 1C). Therefore,
different configuration of rifampicin-binding pocket
may affect NADylation of RNA capping in different
bacteria. In contrast to NAD+, the incorporation of
UDP-containing cell wall precursors was not affected
Figure 1. A. A list of 6 heavily NAD+ modified RNA species found by Cahova et. al., [1] with half-lives reported in [22]. B. Cellular concen-
trations of nucleotides and analogs in E. coli cell reported by Bennett et. al., [9], and the Km for their usage as a substrates in transcription
initiation [8]. C. Regions of RNAP shown to influence capping efficiency. PDB 5D4D structure of Thermus thermophilus RNAP open com-
plex with NADpC was used, NAD is shown in cyan. Part of rifampicin-binding pocket corresponding to cluster I of Rif region of b subunit
is in magenta, region 3.2 of s subunit is in green, template DNA is grey, Mg2+ ions are in ruby.
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by the amino acid substitutions in the rifampicin-
binding pocket.
Cofactors bound at +1 position may potentially
interact with the 3.2 region of initiation factor s70,
which protrudes towards the RNAP active centre [10].
However, we found that a mutant version of s70 lack-
ing region 3.2 (s70D3.2) had no effect on incorporation
of NAD+, NADH, FAD, UDP-Glucose or UDP-
GlcNAc. In contrast, the mature cell wall precursor
UDP-MurNAc-pentapeptide, was incorporated by the
s 70D3.2 mutant of RNAP much more efficiently, sug-
gesting that region 3.2 of s70 may serve to prevent
incorporation of advanced cell wall precursors [8]
(Figure 1C). Region 3.2 is absent from many sigma
factors, suggesting that alternative sigma subunits may
allow capping with bulky substrates.
Decapping enzymes for non-canonical caps
The discovery of NudC (NUDIX nicotinamide pyro-
phosphohydrolase) as an enzyme that removes the
NAD+ cap from RNA made the parallel between clas-
sic eukaryotic and non-canonical capping processes
even more striking. E. coli NudC was initially
described as a housecleaning enzyme hydrolyzing the
pyrophosphate bond of NAD+/NADH to produce nic-
otinamide mononucleotide (NMN+/NMNH) and
AMP [11]. Recently, it was shown than NudC effi-
ciently removes the NAD+/NADH cap to produces
5 0-monophosphorylated RNA [1]. In eukaryotes, the
role of NudC in decapping could be played by NUDIX
hydrolases NPY1 in Saccharomyces cerevisiae and
Nudt19 in Oryza sativa, which both showed decapp-
ing activity in vitro [12]. The activity spectrum of the
bacterial NudC is relatively wide; it can remove several
ADP analogues from RNA in vitro, including DP-CoA
[7], consistent with its hydrolase activity towards a
broad range of dinucleotides [11].
Removal of cap by NudC was proposed to be the
first stage in the degradation of capped RNA to pro-
duce a monophosphorylated species, which are a pre-
ferred substrate for endonuclease RNaseE [13].
Curiously, however, NudC was not associated with
McaS (IsrA) sRNA [14], one of the most highly
NADylated sRNAs in E. coli (Figure 1A), while other
known components of the RNA degradation machin-
ery, such as RNaseE, RNA helicase RhlE and PNPase,
were present [14]. This may suggest that the involve-
ment NudC in RNA maturation might be more
complex. Differential decapping by NudC, and its
association with target RNAs, could be influenced by
the secondary structures of RNAs, as NudC is single-
strand dependent [13].
NudC is orthologous to the RppH NUDIX
hydrolase, which removes pyrophosphate from tri-
phosporylated RNA (leaving 5’ monophosphate)
[15]. A number of additional poorly characterised
NUDIX hydrolases in E. coli [16] suggests that
there might be more potential decapping enzymes
for different caps. Notably, neither NudC nor
RppH are essential for E. coli under normal growth
conditions, suggesting possible redundancy of the
decapping activities.
Human mitochondrial RNAP efficiently caps RNA
with NAD+ and other ADP-containing cofactors
Recently, mitochondrial transcripts capped with
NAD+ were detected in human cells [5]. Mitochondria
contain a major cellular pool of NAD+ (up to 70%),
where it is used for redox reactions and for signalling
[17]. We explored the possibility that mitochondrial
RNAP (mtRNAP) could cap RNA via a mechanism
that is similar to multi-subunit RNAPs. We found
that human mtRNAP (hmRNAP) efficiently initiates
transcription with NAD+, NADH, FAD and DP-CoA
on the light strand promoter (LSP; one of the only two
human mitochondrial promoters) in vitro (Figure 2).
The efficiency of initiation with NAD+ was approxi-
mately 25% compared to ATP, while the other cofac-
tors showed of between 10 to 15%. Our results suggest
that mtRNAP is likely to be responsible for adding a
NAD+ cap to mitochondrial transcripts. Capping in
human mitochondria might have consequences for
both translation and replication in these organelles.
The initially transcribed sequences from both mito-
chondrial promoters are precursors of tRNAs. It is
therefore possible that 5’ NADylation might affect
their maturation process. Additionally, RNA synthes-
ised from the LSP promoter serves as replication
primer [18], and its capping might influence initiation
of replication, primer removal and subsequent DNA
ligation.
Emerging physiological roles of non-canonical
capping
The first experimentally confirmed role for non-
canonical NAD+ cap in bacteria is an increased
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resistance to degradation, shown for RNAI in the
absence of NudC processing [7]. However, this
remains controversial, since in other studies [1] dele-
tion of NudC did not affect the overall stability of the
RNAI and GcvB populations, the two RNAs most
heavily NADylated in vivo. Moreover, overall stability
of NADylated sRNAs varies widely in wild type E.
coli, and there is no direct correlation between NADy-
lation and stability (Figure 1A). Notably, in contrast
to E. coli, NADylation in eukaryotes promotes mRNA
decay [5] via decapping by the DXO enzyme, which
might additionally supply its 5 0-3 0 degradation
activity.
The existence of subpopulations of capped RNA
may play a potential role in bistability, the creation of
phenotypic variability among clonal population that
bacteria use in processes such as dormancy, persis-
tence and sporulation [19]. Capping with dinucleotide
analogues might play role in number of regulatory
processes involving unstable regulatory RNAs. One
example of such process is the type I toxin-antitoxin
systems in bacteria, based on translational repression
of toxin mRNA by an antisense RNA. This idea is sup-
ported by high in vivo NADylation of QUAD (sib)
RNA (Figure 1A) – antitoxin sRNA preventing the
production of the small protein that depolarises the
cellular membrane [20].
The extent of capping could be responsive to the
changes in cellular metabolism. For example, in E.coli,
the proportion of NAD+ capped RNAI found in sta-
tionary phase compared to exponential phase was
two-fold higher [1]. Similarly, in yeast, more capped
RNA was found in cells grown on synthetic media
compared to those grown on the rich media [4]. Since
the NAD+/NADH balance plays key role in cellular
redox homeostasis, capping could connect transcrip-
tion directly to the cell’s redox state. Given the affinity
for NAD+ is roughly the same as for NADH
(Figure 1B), changes in their cellular concentrations
will be directly mirrored by the capping of RNA with
NAD+ or NADH. The functioning of such signalling
of course would depend on a mechanism recognising
NADylated from NADHylated RNAs. UDP-Glucose
and UDP-GlcNAc are the initial substrates for the
cascade of reactions leading to the synthesis of cell
wall components. It would be tempting to speculate
that expression of some cell wall synthesising
enzymes could be controlled directly by the pool of
Figure 2. Human mitochondrial RNAP (hmRNAP) incorporates ADP analogs in vitro. A partial sequence of the light strand promoter (LSP)
is shown, with the initially transcribed sequence underlined. For the assay, 50 nM TFAM, 50 nM hmRNAP, 50 nM TFB2M (purified as
described in [23]) were combined with 50 nM of linear DNA fragment containing LSP promoter (positions -70 to +50) in 10 ml of tran-
scription buffer (40 mM Tris pH 8.0, 10 mM MgCl2, 10 mM DTT), then ATP or ADP analogs were added to the final concentration of
1mM. Transcription was initiated by the addition of 10 mM MgCl2, 50 mM ATP, 300 mM GTP, 10mM [a
32P]-UTP, 25 Ci/mmol (Hartmann
Analytic). After 30 min incubation at 37C, 500 nM NudC was added to half of the reactions and incubated for additional 15 minutes at
37C. Transcripts modified with NAD+, NADH and DP-CoA (but not ATP or FAD) were susceptible to NudC (lanes 5,9,11) judging from
increased mobility of the products. Reactions were stopped by the addition of formamide-containing loading buffer. Products were sep-
arated on denaturing polyacrylamide gels (20% acrylamide, 3% bis-acrylamide, 6M urea, 1xTBE), revealed by PhosphorImaging (GE
Healthcare), and analysed using ImageQuant software (GE Healthcare).
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UDP-GlcNAc via capping of +1U transcripts. In gen-
eral, being rare, RNA modification with cell wall pre-
cursors might provide a better regulatory potential,
compared to ubiquitous capping with ADP analogs.
Capping might potentially influence translation ini-
tiation on a leaderless mRNA.
Another potential cellular role of capping could be
the targeting of a specific RNA species, via its cofactor
cap, to a protein with affinity for the cognate cofactor,
or to a specific subcellular location, e.g. to the vicinity
of the membrane in the case of UDP-GlcNAc capped
RNA.
Intriguingly, we showed that a number of rifampi-
cin resistant RNAPs, including the most widespread
clinical isolates, are deficient in capping [8]. This defi-
ciency may contribute to the overall fitness reduction,
characteristic for a rifampicin resistant strains [21].
To conclude, despite recent progress, the under-
standing of non-canonical RNA capping by RNAPs is
still patchy. More information is needed to put this
type of RNA 5’ modification into the category of
functional capping, rather than a side reaction of
RNAPs. Currently it is hard to envisage a “classic”
regulation by the stochastic process of capping. Never-
theless, this “unavoidable” side reaction has to be
either used to some advantage or, alternatively, fought
against. Both scenarios would have wide ranging cel-
lular consequences with multiple regulatory mecha-
nisms involved. It seems that RNAP has a limited
ability to control capping process, apart from alterna-
tive sigma factors exchange. It is more feasible to reg-
ulate amounts of capped RNA post-transcriptionally,
by the linked processes of decapping, alternative fold-
ing and RNA chaperons binding. Being a stochastic
process, capping might generate variability in a clonal
population, which can be exploited at a population
level to benefit the organism in adaptation to rapid
change in growth conditions. At present, an exact
roles of various non-canonical caps in bacteria, eukar-
yotes and mitochondria are still to be established, as
well as full repertoire of enzymes that process non-
canonically capped RNAs are to be characterised.
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